BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2960860)

  • 1. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes.
    Caligaris-Cappio F; Schena M; Bergui L; Tesio L; Riva M; Rege-Cambrin G; Funaro A; Malavasi F
    Leukemia; 1987 Nov; 1(11):746-52. PubMed ID: 2960860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
    Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
    Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
    Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
    J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
    Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
    Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
    Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi DA; Bonadonna G; Gianni AM
    Cancer Res; 1989 Jun; 49(12):3328-32. PubMed ID: 2785850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation.
    Perri RT; Kay NE
    Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
    Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
    J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
    Perri RT; Wilson BS; Kay NE
    Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
    J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S; Emilie D; Galanaud P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the B8.7 antigen on hairy cells and relation with the LMW-BCGF response.
    Génot E; Leprince C; Richard Y; Petit-Koskas E; Falcoff E; Galanaud P; Sigaux F; Kolb JP
    Leukemia; 1989 May; 3(5):367-72. PubMed ID: 2785622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
    Perri RT
    Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
    Ledbetter JA; Shu G; Gallagher M; Clark EA
    J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
    Petit-Koskas E; Génot E; Lawrence D; Kolb JP
    Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.